SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-008288
Filing Date
2023-03-14
Accepted
2023-03-14 08:30:09
Documents
1
Period of Report
2023-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3668
  Complete submission text file 0000899243-23-008288.txt   5013
Mailing Address P.O. BOX 134 MALVERN PA 19355
Business Address P.O. BOX 134 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Degnan Chris (Reporting) CIK: 0001741968 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 23729267